Evaluation of Serum Interleukin-6 Level as a Surrogate Marker of Synovial Inflammation and as a Factor of Structural Progression in Early Rheumatoid Arthritis: Results From a French National Multicenter Cohort-Reference-Cited by-同舟云学术

Evaluation of Serum Interleukin-6 Level as a Surrogate Marker of Synovial Inflammation and as a Factor of Structural Progression in Early Rheumatoid Arthritis: Results From a French National Multicenter Cohort

Published:2015-06-25 Issue:7 Volume:67 Page:905-912
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Baillet Athan¹,Gossec Laure²,Paternotte Simon³,Etcheto Adrien³,Combe Bernard⁴,Meyer Olivier⁵,Mariette Xavier⁶,Gottenberg Jacques-Eric⁷,Dougados Maxime³

Affiliation:

1. GREPI UJF CNRS; Grenoble France

2. UPMC Université Paris 06, GRC-UPMC 08 (EEMOIS), Assistance Publique Hôpitaux de Paris, Pitié Salpêtrière Hospital; Paris France

3. Paris-Descartes University, Assistance Publique Hôpitaux de Paris, Cochin Hospital; Paris France

4. Lapeyronie University Hospital, Montpellier I University; Montpellier France

5. Université Paris 7 Denis Diderot, UFR de Médecine, and Assistance Publique Hôpitaux de Paris, Hôpital Bichat; Paris France

6. Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Université Paris-Sud, Institut Pour la Santé et la Recherche Médicale Paris, France

7. Strasbourg University Hospital; Strasbourg France

Publisher

Wiley

Subject

Rheumatology

Reference48 articles.

1. Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate;Knudsen;Scand J Rheumatol,2006

2. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis;Vastesaeger;Rheumatology (Oxford),2009

3. Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction;Smolen;Ann Rheum Dis,2012

4. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis;Colebatch;Ann Rheum Dis,2013

5. Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: implications for pathogenesis and evaluation of treatment;Kraan;Arthritis Rheum,2002

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis;Annals of the Rheumatic Diseases;2023-11-24

2. Relationship between laboratory biomarkers and ultrasonographic signs of inflammation in patients with rheumatoid arthritis treated with a rituximab biosimilar;Modern Rheumatology Journal;2022-06-19

3. Relationship of cytokine level dynamics with longterm results of early rheumatoid arthritis therapy;Rheumatology Science and Practice;2022-03-01

4. The association between interleukin-6 promoter polymorphisms and rheumatoid arthritis by ethnicity: A meta-analysis of 33 studies;Reumatología Clínica;2021-10

5. The association between interleukin-6 promoter polymorphisms and rheumatoid arthritis by ethnicity: A meta-analysis of 33 studies;Reumatología Clínica (English Edition);2021-10